Prices delayed by at least 15 minutes | Print
Hutchmed (China) Limited (HCM)
ORD USD0.10Open
201.00p
Previous close
202.00p
Trade high
204.00p
Volume
21,114
Year high
239.00p
Year low
150.48p
Dividend yield
–
Market capitalisation
£1.72 bn
P/E ratio
132.44
ISIN
KYG4672N1198
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 30/10/2026 | 04:35:25 | 198 | 18 | 35.64 |
| 30/10/2026 | 04:28:00 | 204 | 7 | 14.18 |
| 30/10/2026 | 04:11:42 | 199 | 2,004 | 3,987.96 |
| 30/10/2026 | 03:58:35 | 198.985 | 1 | 1.99 |
| 30/10/2026 | 03:11:49 | 197.62 | 19 | 37.55 |